COMMUNIQUÉS West-GlobeNewswire

Found Health Claims Evaluated: Affordable GLP-1 Weight Loss Medication Provider with Free Online Insurance Check
08/04/2026
A 2026 overview of Found Health's GLP-1 medication access model, free online insurance coverage check, disclosed pricing for Wegovy, Zepbound, Ozempic, and compounded semaglutide options, telehealth program structure, [...]
Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference
08/04/2026
BRISBANE, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that [...]
Polyrizon Ltd. Announces Closing of $3.5 Million Registered Direct and Private Placements
08/04/2026
RAANANA, ISRAEL, April 08, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions, today announced the closing of [...]
Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution
08/04/2026
Digital solution will be designed to help guide users through injection process CINCINNATI, April 08, 2026 (GLOBE NEWSWIRE) -- Aptar Digital Health, a global leader in digital health solutions enhancing the patient [...]
Kyntra Bio to Present at the 25th Annual Needham Virtual Healthcare Conference
08/04/2026
SAN FRANCISCO, April 08, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio (Nasdaq: KYNB) today announced that the Company will present at the 25 th Annual Needham Virtual Healthcare Conference being held April 13-16, 2026. Thane [...]
Telix Strengthens Board with Additional Director Appointments
09/04/2026
MELBOURNE, Australia and INDIANAPOLIS, April 09, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces two additional Non-Executive Director (NED) appointments, [...]
ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results
08/04/2026
PORTLAND, Maine, April 08, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops, manufactures and markets products to improve calf [...]
Inventiva announces filing of its 2025 Universal Registration Document and 2025 Annual Report on Form 20-F
08/04/2026
Daix (France), New York City (New York, United States), April 8, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies [...]
Neura Supplement Claims Evaluated: The 7-Second Red Goji Berry Recipe Memory Trick for Neura Shield Cognitive Performance
08/04/2026
A 2026 informational consumer report on the Neura Supplement red goji berry recipe memory trick, cognitive shield claims, Lion's Mane and Bacopa ingredient research context, dementogen positioning, and what adults over [...]
New 23andMe Research Institute Study Identifies Genetic Predictors for GLP-1 Weight Loss Efficacy and Side Effects
08/04/2026
23andMe turns research into useful genetic insights, now offering a new GLP-1 report and interactive tool through 23andMe Total Health PALO ALTO, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- 23andMe Research Institute, a [...]
Ascendis Pharma to List Ordinary Shares Directly on Nasdaq
08/04/2026
- Ordinary shares expected to commence trading on Nasdaq on April 20, 2026 following exchange of all American Depositary Shares (ADSs) - ADS holders will receive one ordinary share listed on Nasdaq for each ADS held - [...]
Booking Health Releases 2026 Report on Advanced Head and Neck Cancer Treatment for International Patients
08/04/2026
Langenfeld, Germany, April 08, 2026 (GLOBE NEWSWIRE) -- Booking Health , a global medical travel provider, announced today the release of its 2026 report on advanced head and neck cancer treatment for international [...]
Sanofi - Assemblée Générale Mixte du 29 avril 2026 - Mise à disposition des documents préparatoires
08/04/2026
ASSEMBLÉE GÉNÉRALE MIXTE DU 29 AVRIL 2026 MODALITÉS DE MISE À DISPOSITION OU DE CONSULTATION DES DOCUMENTS PRÉPARATOIRES Les actionnaires de la Société sont invités à participer à l’assemblée générale mixte qui se [...]
Trogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model
08/04/2026
A single-dose of Trogenix’s proprietary Synthetic Super-Enhancers achieved complete tumour elimination in 83% of treated cases with no toxicity over 11 months and no tumour recurrence in a brain cancer model that [...]
Sanofi - Combined General Meeting of April 29, 2026 - Availability of Preparatory documents
08/04/2026
COMBINED GENERAL MEETING OF APRIL 29, 2026 AVAILABILITY OF PREPARATORY DOCUMENTS The Company’s shareholders are invited to attend the Combined General Meeting to be held on Wednesday April 29, 2026 at 2:30 p.m. (CET) at [...]
Psyence BioMed Expands Australian Clinical Site Network to Five Sites, Advancing NPX-5–Supported Clinical Activities
08/04/2026
Expansion supports accelerated enrollment and advancement of the Company’s lead clinical asset NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a [...]
BioPorto Successfully Completes Divestment of its Antibody Business to Janel Life Sciences, LLC
08/04/2026
April 8, 2026 Company Announcement No. 7 BioPorto Successfully Completes Divestment of its Antibody Business to Janel Life Sciences, LLC COPENHAGEN, DENMARK and BOSTON, MA, USA, April 8, 2026 – BioPorto A/S (“BioPorto” [...]
New Data from Week 52 of the Ongoing COACH Trial Showed that TransCon® hGH Accelerated TransCon® CNP’s Benefits Beyond Linear Growth in Children with Achondroplasia
08/04/2026
- Unprecedented improvements in arm span observed with TransCon CNP and TransCon hGH combination therapy, a measure highly meaningful to the achondroplasia community - Enhanced improvements in spinal canal dimensions [...]
RenovoRx Secures First Notice of Allowance for Japanese Patent Covering its RenovoCath® Device for Targeted, Local Drug-Delivery via the Vasa Vasorum
08/04/2026
Patent Expands Protection for the Company’s RenovoCath Device, the Novel Dual-Occlusion Catheter-Based System RenovoRx Currently Holds a Strong and Growing Global Intellectual Property Portfolio with 19 Issued or [...]

Pages